Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Standard BioTools (LAB)
NASDAQ:LAB
Standard BioTools (LAB) Stock Price & Analysis
424 Followers
LAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.57 - $3.16
Previous Close$2.19
Volume1.49M
Average Volume (3M)3.20M
Market Cap
$811.22M
Enterprise Value$440.84M
Total Cash (Recent Filing)$462.28M
Total Debt (Recent Filing)$91.90M
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Jul 31, 2024EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding372,141,530
10 Day Avg. Volume2,490,058
30 Day Avg. Volume3,197,988
Standard Deviation0.26
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.81
Price to Sales (P/S)15.77
Price to Cash Flow (P/CF)-12.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.48
Enterprise Value/Gross Profit8.74
Enterprise Value/Ebitda-5.67
Forecast
1Y Price Target
$3.50Price Target Upside59.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Standard BioTools News
Ownership Overview
30.70% Insiders
6.63% Mutual Funds
14.18% Other Institutional Investors
48.49% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LAB FAQ
What was Standard BioTools’s price range in the past 12 months?
Standard BioTools lowest stock price was $1.57 and its highest was $3.16 in the past 12 months.
What is Standard BioTools’s market cap?
Currently, no data Available
When is Standard BioTools’s upcoming earnings report date?
Standard BioTools’s upcoming earnings report date is Jul 31, 2024 which is in 9 days.
How were Standard BioTools’s earnings last quarter?
Standard BioTools released its earnings results on May 08, 2024. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.112 by -$0.158.
Is Standard BioTools overvalued?
According to Wall Street analysts Standard BioTools’s price is currently Undervalued.
Does Standard BioTools pay dividends?
Standard BioTools does not currently pay dividends.
What is Standard BioTools’s EPS estimate?
Standard BioTools’s EPS estimate is -$0.08.
How many shares outstanding does Standard BioTools have?
Standard BioTools has 370,421,480 shares outstanding.
What happened to Standard BioTools’s price movement after its last earnings report?
Standard BioTools reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.112. Following the earnings report the stock price went up 7.589%.
Which hedge fund is a major shareholder of Standard BioTools?
Among the largest hedge funds holding Standard BioTools’s share is Viking Global Investors LP. It holds Standard BioTools’s shares valued at 159M.
---
Standard BioTools Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (59.82% Upside)
$3.50 (59.82% Upside)
Blogger Sentiment
Bullish
LAB Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 73.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.50%
12-Months-Change
Fundamentals
Return on Equity
-37.47%
Trailing 12-Months
Asset Growth
109.24%
Trailing 12-Months
Company Description
Standard BioTools
Fluidigm Corp. is engaged in the development, manufacture and marketing of biotechnology tools fro life sciences research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics; and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen R. Quake and Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
---
LAB Company Deck
---
LAB Earnings Call
Q1 2024
0:00 / 0:00
---
LAB Stock 12 Month Forecast
Average Price Target
$3.50
▲(59.82% Upside)
Technical Analysis
Best Analysts Covering LAB
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
+5.55%
reiterated a buy rating last month
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.55% per trade.
---